Literature DB >> 15195286

Permutation tests for factorially designed neuroimaging experiments.

John Suckling1, Ed Bullmore.   

Abstract

Permutation methods for analysis of functional neuroimaging data acquired as factorially designed experiments are described and validated. The F ratio was estimated for main effects and interactions at each voxel in standard space. Critical values corresponding to probability thresholds were derived from a null distribution sampled by appropriate permutation of observations. Spatially informed, cluster-level test statistics were generated by applying a preliminary probability threshold to the voxel F maps and then computing the sum of voxel statistics in each of the resulting three-dimensional clusters, i.e., cluster "mass." Using simulations comprising two between- or within-subject factors each with two or three levels, contaminated by Gaussian and non-normal noise, the voxel-wise permutation test was compared to the standard parametric F test and to the performance of the spatially informed statistic using receiver operating characteristic (ROC) curves. Validity of the permutation-testing algorithm and software is endorsed by almost identical performance of parametric and permutation tests of the voxel-level F statistic. Permutation testing of suprathreshold voxel cluster mass, however, was found to provide consistently superior sensitivity to detect simulated signals than either of the voxel-level tests. The methods are also illustrated by application to an experimental dataset designed to investigate effects of antidepressant drug treatment on brain activation by implicit sad facial affect perception in patients with major depression. Antidepressant drug effects in left amygdala and ventral striatum were detected by this software for an interaction between time (within-subject factor) and group (between-subject factor) in a representative two-way factorial design. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195286      PMCID: PMC6871945          DOI: 10.1002/hbm.20027

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  20 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.

Authors:  Y I Sheline; D M Barch; J M Donnelly; J M Ollinger; A Z Snyder; M A Mintun
Journal:  Biol Psychiatry       Date:  2001-11-01       Impact factor: 13.382

3.  Genetic influences on brain structure.

Authors:  P M Thompson; T D Cannon; K L Narr; T van Erp; V P Poutanen; M Huttunen; J Lönnqvist; C G Standertskjöld-Nordenstam; J Kaprio; M Khaledy; R Dail; C I Zoumalan; A W Toga
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

4.  Time series analysis in the time domain and resampling methods for studies of functional magnetic resonance brain imaging.

Authors:  J J Locascio; P J Jennings; C I Moore; S Corkin
Journal:  Hum Brain Mapp       Date:  1997       Impact factor: 5.038

5.  Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold.

Authors:  S D Forman; J D Cohen; M Fitzgerald; W F Eddy; M A Mintun; D C Noll
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

6.  Methods for diagnosis and treatment of stimulus-correlated motion in generic brain activation studies using fMRI.

Authors:  E T Bullmore; M J Brammer; S Rabe-Hesketh; V A Curtis; R G Morris; S C Williams; T Sharma; P K McGuire
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

7.  Assessing the significance of focal activations using their spatial extent.

Authors:  K J Friston; K J Worsley; R S Frackowiak; J C Mazziotta; A C Evans
Journal:  Hum Brain Mapp       Date:  1994       Impact factor: 5.038

Review 8.  Nonparametric analysis of statistic images from functional mapping experiments.

Authors:  A P Holmes; R C Blair; J D Watson; I Ford
Journal:  J Cereb Blood Flow Metab       Date:  1996-01       Impact factor: 6.200

9.  Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

Authors:  G D Honey; E T Bullmore; W Soni; M Varatheesan; S C Williams; T Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

10.  Practice and difficulty evoke anatomically and pharmacologically dissociable brain activation dynamics.

Authors:  Ed Bullmore; John Suckling; Fernando Zelaya; Chris Long; Garry Honey; Laurence Reed; Carol Routledge; Virginia Ng; Paul Fletcher; John Brown; Steve C R Williams
Journal:  Cereb Cortex       Date:  2003-02       Impact factor: 5.357

View more
  31 in total

1.  General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.

Authors:  Alex Fornito; Jong Yoon; Andrew Zalesky; Edward T Bullmore; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2011-04-22       Impact factor: 13.382

2.  A statistical method (cross-validation) for bone loss region detection after spaceflight.

Authors:  Qian Zhao; Wenjun Li; Caixia Li; Philip W Chu; John Kornak; Thomas F Lang; Jiqian Fang; Ying Lu
Journal:  Australas Phys Eng Sci Med       Date:  2010-07-15       Impact factor: 1.430

3.  Dopaminergic receptor blockade changes a functional connectivity network centred on the amygdala.

Authors:  Jan Haaker; Mareike M Menz; Tahmine Fadai; Falk Eippert; Christian Büchel
Journal:  Hum Brain Mapp       Date:  2016-11       Impact factor: 5.038

4.  Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes.

Authors:  Ulrich Müller; J Suckling; F Zelaya; G Honey; H Faessel; S C R Williams; C Routledge; J Brown; T W Robbins; E T Bullmore
Journal:  Psychopharmacology (Berl)       Date:  2005-09-14       Impact factor: 4.530

5.  Predicting the brain response to treatment using a Bayesian hierarchical model with application to a study of schizophrenia.

Authors:  Ying Guo; F DuBois Bowman; Clinton Kilts
Journal:  Hum Brain Mapp       Date:  2008-09       Impact factor: 5.038

6.  Monofractal and multifractal dynamics of low frequency endogenous brain oscillations in functional MRI.

Authors:  Alle-Meije Wink; Ed Bullmore; Anna Barnes; Frederic Bernard; John Suckling
Journal:  Hum Brain Mapp       Date:  2008-07       Impact factor: 5.038

7.  Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia.

Authors:  Yujiro Yoshihara; Genichi Sugihara; Hideo Matsumoto; John Suckling; Katsuhiko Nishimura; Takao Toyoda; Haruo Isoda; Kenji J Tsuchiya; Kiyokazu Takebayashi; Katsuaki Suzuki; Harumi Sakahara; Kazuhiko Nakamura; Norio Mori; Nori Takei
Journal:  Ann Gen Psychiatry       Date:  2008-12-22       Impact factor: 3.455

8.  Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study.

Authors:  Samuel R Chamberlain; Lara A Menzies; Naomi A Fineberg; Natalia Del Campo; John Suckling; Kevin Craig; Ulrich Müller; Trevor W Robbins; Edward T Bullmore; Barbara J Sahakian
Journal:  Br J Psychiatry       Date:  2008-09       Impact factor: 9.319

9.  CamBAfx: Workflow Design, Implementation and Application for Neuroimaging.

Authors:  Cinly Ooi; Edward T Bullmore; Alle-Meije Wink; Levent Sendur; Anna Barnes; Sophie Achard; John Aspden; Sanja Abbott; Shigang Yue; Manfred Kitzbichler; David Meunier; Voichita Maxim; Raymond Salvador; Julian Henty; Roger Tait; Naresh Subramaniam; John Suckling
Journal:  Front Neuroinform       Date:  2009-08-28       Impact factor: 4.081

10.  Enhanced activation of the left inferior frontal gyrus in deaf and dyslexic adults during rhyming.

Authors:  Mairéad MacSweeney; Michael J Brammer; Dafydd Waters; Usha Goswami
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.